Aspiration Therapy for Obese Adolescents

NCT ID: NCT03598920

Last Updated: 2022-12-07

Basic Information

• Recruitment Status: COMPLETED
• Total Enrollment: 20 participants
• Study Classification: OBSERVATIONAL
• Study Start Date: 2018-08-01
• Study Completion Date: 2021-12-31

Brief Summary

Interventional studies devoted to adolescents are relatively rare in the world. This has several reasons. Treatment and research on obesity are centered on advanced forms of obesity in adults, bearing in mind that social and health problems make these patients cope with their condition. Studies on children tend to focus on epidemiology. On the other hand, effective long-term effective treatment is not just for young adults and adolescents. However, appropriate long-term weight reduction methods could help with chronic obesity at the onset of the disease. Here, the ideal scheme at the outset of the disease is to use less invasive endoscopic methods and then use invasive surgical methods at a later age.

The benefit of this study will certainly be to find out the reality of the use of this endoscopic method in young obese individuals, that is, population groups where, according to the WHO and CDC (Centers for Disease Control and Prevention), there has been a rapid increase in the incidence of obesity especially during the last 20 years.

Detailed Description

The aim of the project is the testing and research of the impact on metabolism using the approved bariatric method AspireAssist, which is currently used in the adult population. The method has been approved by FDA since 2016. The method involves the introduction of percutaneous endoscopic gastrostomy (PEG) that allows the aspiration of a portion of the food and the control of the size and volume of the food received, even in the unmanaged size and volume of food intake.

Potential participants of the study will undergo an initial examination at the clinical department of pediatric medicine specializing in obesitology at the Vítkovice Hospital Ostrava a.s. In addition to a pediatric and internal examination, a potential patient will be examined by a clinical psychologist for the ability to participate in such a type of study on a long-term basis, and will further assess the degree of patient support and co-operation. Selected participants in the study or their family members will receive informed consent. A study participant is considered to be a participant in the study after consent to his / her inclusion in the study after the informed consent has been signed. The AspireAssist aspiration device is the definitive participation in the study.

Two parts will be monitored within the project. (1) Safety and efficacy will be assessed first in young obese patients for whom the use of bariatric methods is still a question of discussion, especially in surgical methods. (2) The second objective is to monitor the saccharide and lipid metabolism, GI hormones and also the impact of the AspireAssist method on the nutritional status of the adolescents studied.

The patients enrolled in the study are followed for the period of twelve months.

Timetable of the study procedures and controls:

Preoperative examination:

• Demographic data on age, sex, weight, height, smoking
• Assessment of body composition and sampling of blood
• Questionnaires for the quality of Life Examination 3 months postoperatively
• Assessment of body composition and sampling of blood
• Questionnaires for the quality of Life Examination 6 months after surgery
• Assessment of body composition and sampling of blood
• Questionnaires for the quality of Life Examination 12 months after surgery
• Assessment of body composition and sampling of blood
• Questionnaires for the quality of Life

Statistical data processing for statistical evaluation descriptive statistics is used (arithmetical average, standard deflection, frequency tables), X2 test, Fisher's exact test, analysis of variance (ANOVA), calculating of the OR (odds ratio) with 95 % confidence intervals, and logistic regression. Statistical tests are evaluated at the significance level of 5%. Statistical analysis is performed in the "Stata 10" programme. Program EpiData is used for data collection.

Conditions

Obesity, Morbid

Study Design

• Observational Model Type: COHORT
• Study Time Perspective: PROSPECTIVE

Study Groups

AspireAssist

Patients undergoing the endoscopic bariatric procedure using the AsspireAssist device

AsspireAssist

Intervention Type: DEVICE

Endoscopic bariatric procedure using the AsspireAssist device

Nutritional consulting

Patients undergoing nutritional consulting

Nutritional consulting

Intervention Type: OTHER

Nutritional consulting provided by a specialized consultant.

Interventions

AsspireAssist

Endoscopic bariatric procedure using the AsspireAssist device

Intervention Type: DEVICE

Nutritional consulting

Nutritional consulting provided by a specialized consultant.

Intervention Type: OTHER

Eligibility Criteria

Inclusion Criteria

• history of conservative obesity treatments selected according to criteria IFSO (BMI greater than 40 or greater than 35 with comorbidities)

Exclusion Criteria

• Diabetes Type I.
• blood clotting disorder
• using of Insulin
• psychiatric disorders
• monogenic obesity (Prader-Willi syndrome, mutation of MC4R).
• thyroid disease
• diseases of the digestive system associated with disorders of intestinal absorption
• history of corticosteroid therapy in the past 12 months
• history of bulimia and other eating disorders

• Minimum Eligible Age: 16 Years
• Maximum Eligible Age: 21 Years
• Eligible Sex: ALL
• Accepts Healthy Volunteers: No

Sponsors

University of Ostrava

OTHER

Sponsor Role: collaborator

Vítkovice Hospital Ostrava, Czech Republic

UNKNOWN

Sponsor Role: collaborator

University Hospital Ostrava

OTHER

Sponsor Role: lead

Responsible Party

Responsibility Role: SPONSOR

Principal Investigators

Evžen Machytka, MD,Ph.D.

Role: PRINCIPAL_INVESTIGATOR

University Hospital Ostrava

Locations

Ostrava University

Ostrava, Moravian-Silesian Region, Czechia

Vítkovice Hospital Ostrava

Ostrava, Moravian-Silesian Region, Czechia

University Hospital Ostrava

Ostrava, Moravian-Silesian Region, Czechia

Countries

Czechia

References

Nystrom M, Machytka E, Noren E, Testoni PA, Janssen I, Turro Homedes J, Espinos Perez JC, Turro Arau R. Aspiration Therapy As a Tool to Treat Obesity: 1- to 4-Year Results in a 201-Patient Multi-Center Post-Market European Registry Study. Obes Surg. 2018 Jul;28(7):1860-1868. doi: 10.1007/s11695-017-3096-5.

Reference Type: BACKGROUND

PMID: 29388050 (View on PubMed)

Sullivan S, Edmundowicz SA, Thompson CC. Endoscopic Bariatric and Metabolic Therapies: New and Emerging Technologies. Gastroenterology. 2017 May;152(7):1791-1801. doi: 10.1053/j.gastro.2017.01.044. Epub 2017 Feb 10.

Reference Type: BACKGROUND

PMID: 28192103 (View on PubMed)

Abu Dayyeh BK, Edmundowicz S, Thompson CC. Clinical Practice Update: Expert Review on Endoscopic Bariatric Therapies. Gastroenterology. 2017 Mar;152(4):716-729. doi: 10.1053/j.gastro.2017.01.035. Epub 2017 Jan 29.

Reference Type: BACKGROUND

PMID: 28147221 (View on PubMed)

Kumar N, Sullivan S, Thompson CC. The role of endoscopic therapy in obesity management: intragastric balloons and aspiration therapy. Diabetes Metab Syndr Obes. 2017 Jul 6;10:311-316. doi: 10.2147/DMSO.S95118. eCollection 2017.

Reference Type: BACKGROUND

PMID: 28740414 (View on PubMed)

Sullivan S. Aspiration Therapy for Obesity. Gastrointest Endosc Clin N Am. 2017 Apr;27(2):277-288. doi: 10.1016/j.giec.2016.12.001.

Reference Type: BACKGROUND

PMID: 28292406 (View on PubMed)

Kumbhari V, Okolo PI III. Editorial: Aspiration Therapy for Weight Loss: Is the Squeeze worth the Juice? Am J Gastroenterol. 2017 Mar;112(3):458-589. doi: 10.1038/ajg.2017.2.

Reference Type: BACKGROUND

PMID: 28270668 (View on PubMed)

ASGE Bariatric Endoscopy Task Force; ASGE Technology Committee; Abu Dayyeh BK, Edmundowicz SA, Jonnalagadda S, Kumar N, Larsen M, Sullivan S, Thompson CC, Banerjee S. Endoscopic bariatric therapies. Gastrointest Endosc. 2015 May;81(5):1073-86. doi: 10.1016/j.gie.2015.02.023. Epub 2015 Mar 28. No abstract available.

Reference Type: BACKGROUND

PMID: 25828245 (View on PubMed)

Devault KR. Could aspiration therapy for obesity be an effective and safe alternative to traditional bariatric surgery? Gastroenterology. 2013 Dec;145(6):1188-90. doi: 10.1053/j.gastro.2013.10.038. No abstract available.

Reference Type: BACKGROUND

PMID: 24409479 (View on PubMed)

Sullivan S, Stein R, Jonnalagadda S, Mullady D, Edmundowicz S. Aspiration therapy leads to weight loss in obese subjects: a pilot study. Gastroenterology. 2013 Dec;145(6):1245-52.e1-5. doi: 10.1053/j.gastro.2013.08.056. Epub 2013 Sep 6.

Reference Type: BACKGROUND

PMID: 24012983 (View on PubMed)

Forssell H, Noren E. A novel endoscopic weight loss therapy using gastric aspiration: results after 6 months. Endoscopy. 2015 Jan;47(1):68-71. doi: 10.1055/s-0034-1378097. Epub 2014 Sep 30.

Reference Type: BACKGROUND

PMID: 25268305 (View on PubMed)

Other Identifiers

FNO-IK-Aspiration

Identifier Type: -

Identifier Source: org_study_id